Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Vitrolife AB is a medical device company. It develops, produces, and markets products for creating, prolonging, and improving life. The company's geographical segment includes EMEA, North and South America, Japan and Pacific and Asia. It derives a majority of revenue from the EMEA region. The company's product categories include Oocyte retrieval Needles; Sperm processing; IVF media and oil; Micromanipulation pipettes; Labware; Benchtop incubators; Time-lapse systems; Preimplantation Genetic Testing (PGT); Cryopreservation; Laser and imaging systems and Lab QC systems.
Gothenburg, 400 92, Sweden